Activation of FGFR1 on breast cancer cells, as well as on stromal cells in the TME, initiates the production of the chemokine CX3CL1 (fractalkine) that recruits CX3CR1-expressing macrophages/monocytes to the TME (38). Here, CX3CL1 is linked to breast carcinoma.